<DOC>
	<DOCNO>NCT00060918</DOCNO>
	<brief_summary>To evaluate effect two different antihypertensive medication drug class beta-blockers control glucose Type II diabetic patient high blood pressure .</brief_summary>
	<brief_title>Glycemic Control Of Carvedilol Versus Metoprolol In Patients With Type II Diabetes Mellitus And Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Carvedilol</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<criteria>Inclusion criterion : Patients screen must insulin produce Type II diabetic ( C peptide positive ) . Must history mild moderate hypertension ( 140179 systolic ; 9019 diastolic ) . Must stable regimen ACE ( angiotensin convert enzyme ) / ARB ( angiotensin receptor blocker ) treatment alone combination treatment . Patient '' laboratory result HbA1c must 6.5 8.5 ( drug treat ) 6.5 7.5 ( diet alone ) . Must stable antidiabetic regimen ( drug treat diet alone ) . Exclusion criterion : Patients use betablocker therapy .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Type 2 diabetes</keyword>
	<keyword>hypertension</keyword>
	<keyword>beta-blockers</keyword>
</DOC>